Joel Greenblatt · Magic Formula: alto retorno sobre o capital a um EV/EBIT baixo
Is Alnylam Pharmaceuticals, Inc. (ALNY) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
59/100
Misto
1/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a ALNY
EBIT/EV yield ≥ 10%
chave1.3%
ROIC ≥ 25%
chave19.7%
EV/EBIT ≤ 12
77.8x
Gross margin ≥ 30%
80.9%
Como ALNY pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$29.4B
P/L (TTM)
68.1x
ROIC (TTM)
19.66%
Margem bruta
80.89%
Outras análises Joel Greenblatt
Perguntas frequentes
What is ALNY's Joel Greenblatt fit score?
ALNY scores 59/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own ALNY?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ALNY.
How often is this score updated?
ALNY's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende ALNY pessoalmente.
